机译:HIV,HCV,HBV-NAT测定的血液供体筛选的有效性以及德国HBsAg和抗HBC免疫测定(2008-2015)
Safety of Medicinal Products and Medical DevicesPaul‐Ehrlich‐InstitutLangen Germany;
Safety of Medicinal Products and Medical DevicesPaul‐Ehrlich‐InstitutLangen Germany;
Testing Laboratory for in?vitro diagnostic devices Paul‐Ehrlich;
Testing Laboratory for in?vitro diagnostic devices Paul‐Ehrlich;
Section?of Transfusion MedicinePaul‐Ehrlich‐InstitutLangen Germany;
Safety of Medicinal Products and Medical DevicesPaul‐Ehrlich‐InstitutLangen Germany;
Safety of Medicinal Products and Medical DevicesPaul‐Ehrlich‐InstitutLangen Germany;
Safety of Medicinal Products and Medical DevicesPaul‐Ehrlich‐InstitutLangen Germany;
antibody to hepatitis B core antigen; blood safety; hemovigilance; Hepatitis B virus; hepatitis C virus; human immunodeficiency virus type 1; nucleic acid amplification technique;
机译:HIV,HCV,HBV-NAT测定的血液供体筛选的有效性以及德国HBsAg和抗HBC免疫测定(2008-2015)
机译:在日本,患者的HBV和HCV感染的显着背景发生率以及来自抗HBc效价低或抗HBs效价高的抗HBc效价高的供体的输血风险:一项通过输血传播的HBV的前瞻性,单独NAT研究, HCV和HIV感染
机译:一项国际多中心评估研究中的两种针对HBsAG,抗HBc,抗HCV和HIV组合免疫分析的筛查系统的正面对比(第109卷,第114页,2015年)
机译:南非献血者HIV-1和HCV RNA的研究。
机译:血腥病毒感染HBV,HCV,艾滋病毒 - 护士中职业风险和预防=血液接触性病毒感染 - 乙型肝炎,C,艾滋病 - 护士中的专业风险和预防
机译:通过高敏感的分子测定抗HBC阳性/ HBsAg-阴性患者经常揭示胆汁HBV复制活性并通过整合古典和新的血清学HBV标记来预测
机译:HIV,HCV,HBV-NAT测定的血液供体筛选的有效性以及德国HBsAg和抗HBC免疫测定(2008-2015)